ALPS Partners Axiocell
Alps Group is rolling out an internal patient-derived organoid program for personalized cancer treatment in partnership with Dr. Kong Wai Mun of Axiocell Biotech
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Alps Group is rolling out an internal patient-derived organoid program for personalized cancer treatment in partnership with Dr. Kong Wai Mun of Axiocell Biotech